300149.SZ
睿智医药
SZSE · M 科研服务 · CN
CNY 9.70
−6.55%Margins
Gross margin
27.4%
EBITDA margin
10.6%
EBIT margin
-0.8%
Net margin
-1.0%
FCF margin
13.5%
-0.9%
Return on equity
-0.6%
Return on assets
-0.6%
Return on invested capital
0.56x
Asset turnover
CNY 221.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026